• Something wrong with this record ?

Long-term myocardial effects of noninvasive ventilation in patients with obesity hypoventilation syndrome

I. Paranicova, S. Bodnarova, I. Trojova, Z. Hertelyova, Z. Gulasova, I. Cimbolakova, S. Genzor, P. Joppa, R. Tkacova, P. Pobeha

. 2024 ; 231 (-) : 107735. [pub] 20240706

Language English Country England, Great Britain

Document type Journal Article

Grant support
APVV-16-0158, AND VEGA 1/0220/17 Slovak Research and Development Agency
1/0393/22 Ministry of Education, Slovakia.

INTRODUCTION: Chronic effects of noninvasive ventilation on myocardial function in patients with obesity hypoventilation syndrome (OHS) are scarcely understood. The aim of the present study was to evaluate the long-term effects of volume-targeted bilevel positive airway pressure ventilation (BiPAP) on cardiac parameters and myocardial biomarkers in patients with OHS. METHODS: Clinically stable patients with OHS referred to the tertiary center for the initiation of long-term BiPAP therapy were consecutively enrolled. At baseline, all participants underwent overnight cardiorespiratory polygraphy. BiPAP therapy using volume-targeted spontaneous/timed mode delivered via an oro-nasal mask was initiated. Beat-to-beat noninvasive monitoring by impedance cardiography was used to assess heart function at baseline and after 3 and 12 months of BiPAP use. Serum troponin 1, N-Terminal Pro-B-Type Natriuretic Peptide (NT-ProBNP), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) were monitored. RESULTS: Thirteen patients (10 men; mean age, 55.8 ± 9.8 years; mean body mass index of 47.8 ± 5.9 kg/m2) were recruited. From baseline to 3, and to 12 months of BiPAP use, left ventricular stroke volume (SV), ejection time (LVET), and ejection time index significantly increased (P = 0.030; P < 0.001; P = 0.003, respectively), while heart rate and systolic time ratio significantly decreased (P = 0.004; P = 0.034, respectively). Reductions in serum NT-proBNP, IL-6 and TNF-α were observed (P = 0.045; P = 0.018; P = 0.003, respectively). No significant changes in serum troponin were detected throughout the study. CONCLUSIONS: The present findings of increased SV, in association with lengthening of LVET, reductions of NT-proBNP and reductions in circulatory inflammatory markers in patients with stable OHS and chronic moderate-to-severe daytime hypercapnia treated with BiPAP over 1 year support the role of this therapeutic mode in such patients.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019117
003      
CZ-PrNML
005      
20241024111557.0
007      
ta
008      
241015e20240706enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.rmed.2024.107735 $2 doi
035    __
$a (PubMed)38977108
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Paranicova, I $u Department of Respiratory Medicine and Tuberculosis, P.J. Safarik University, Faculty of Medicine, and L. Pasteur University Hospital, Kosice, Slovakia
245    10
$a Long-term myocardial effects of noninvasive ventilation in patients with obesity hypoventilation syndrome / $c I. Paranicova, S. Bodnarova, I. Trojova, Z. Hertelyova, Z. Gulasova, I. Cimbolakova, S. Genzor, P. Joppa, R. Tkacova, P. Pobeha
520    9_
$a INTRODUCTION: Chronic effects of noninvasive ventilation on myocardial function in patients with obesity hypoventilation syndrome (OHS) are scarcely understood. The aim of the present study was to evaluate the long-term effects of volume-targeted bilevel positive airway pressure ventilation (BiPAP) on cardiac parameters and myocardial biomarkers in patients with OHS. METHODS: Clinically stable patients with OHS referred to the tertiary center for the initiation of long-term BiPAP therapy were consecutively enrolled. At baseline, all participants underwent overnight cardiorespiratory polygraphy. BiPAP therapy using volume-targeted spontaneous/timed mode delivered via an oro-nasal mask was initiated. Beat-to-beat noninvasive monitoring by impedance cardiography was used to assess heart function at baseline and after 3 and 12 months of BiPAP use. Serum troponin 1, N-Terminal Pro-B-Type Natriuretic Peptide (NT-ProBNP), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) were monitored. RESULTS: Thirteen patients (10 men; mean age, 55.8 ± 9.8 years; mean body mass index of 47.8 ± 5.9 kg/m2) were recruited. From baseline to 3, and to 12 months of BiPAP use, left ventricular stroke volume (SV), ejection time (LVET), and ejection time index significantly increased (P = 0.030; P < 0.001; P = 0.003, respectively), while heart rate and systolic time ratio significantly decreased (P = 0.004; P = 0.034, respectively). Reductions in serum NT-proBNP, IL-6 and TNF-α were observed (P = 0.045; P = 0.018; P = 0.003, respectively). No significant changes in serum troponin were detected throughout the study. CONCLUSIONS: The present findings of increased SV, in association with lengthening of LVET, reductions of NT-proBNP and reductions in circulatory inflammatory markers in patients with stable OHS and chronic moderate-to-severe daytime hypercapnia treated with BiPAP over 1 year support the role of this therapeutic mode in such patients.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a ženské pohlaví $7 D005260
650    12
$a hypoventilační syndrom při obezitě $x terapie $x patofyziologie $7 D010845
650    12
$a neinvazivní ventilace $x metody $7 D063087
650    12
$a natriuretický peptid typu B $x krev $7 D020097
650    12
$a biologické markery $x krev $7 D015415
650    12
$a interleukin-6 $x krev $7 D015850
650    12
$a peptidové fragmenty $x krev $7 D010446
650    _2
$a TNF-alfa $x krev $7 D014409
650    _2
$a troponin I $x krev $7 D019210
650    _2
$a senioři $7 D000368
650    _2
$a časové faktory $7 D013997
650    _2
$a kardiografie impedanční $7 D002307
650    _2
$a ventilace umělá s výdechovým přetlakem $x metody $7 D011175
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bodnarova, S $u Department of Respiratory Medicine and Tuberculosis, P.J. Safarik University, Faculty of Medicine, and L. Pasteur University Hospital, Kosice, Slovakia
700    1_
$a Trojova, I $u Department of Respiratory Medicine and Tuberculosis, P.J. Safarik University, Faculty of Medicine, and L. Pasteur University Hospital, Kosice, Slovakia
700    1_
$a Hertelyova, Z $u Center of Clinical and Preclinical Research MEDIPARK, P.J. Safarik University, Faculty of Medicine, Kosice, Slovakia
700    1_
$a Gulasova, Z $u Center of Clinical and Preclinical Research MEDIPARK, P.J. Safarik University, Faculty of Medicine, Kosice, Slovakia
700    1_
$a Cimbolakova, I $u Institute of Physical Education and Sport, P.J. Safarik University, Kosice, Slovakia
700    1_
$a Genzor, S $u Department of Respiratory Medicine and Tuberculosis, University Hospital Olomouc and Faculty of Medicine and Dentistry Palacky University, Olomouc, Czech Republic
700    1_
$a Joppa, P $u Department of Respiratory Medicine and Tuberculosis, P.J. Safarik University, Faculty of Medicine, and L. Pasteur University Hospital, Kosice, Slovakia
700    1_
$a Tkacova, R $u Department of Respiratory Medicine and Tuberculosis, P.J. Safarik University, Faculty of Medicine, and L. Pasteur University Hospital, Kosice, Slovakia
700    1_
$a Pobeha, P $u Department of Respiratory Medicine and Tuberculosis, P.J. Safarik University, Faculty of Medicine, and L. Pasteur University Hospital, Kosice, Slovakia. Electronic address: pavol.pobeha@upjs.sk
773    0_
$w MED00004105 $t Respiratory medicine $x 1532-3064 $g Roč. 231 (20240706), s. 107735
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38977108 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111551 $b ABA008
999    __
$a ok $b bmc $g 2201752 $s 1231090
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 231 $c - $d 107735 $e 20240706 $i 1532-3064 $m Respiratory medicine $n Respir Med $x MED00004105
GRA    __
$a APVV-16-0158, AND VEGA 1/0220/17 $p Slovak Research and Development Agency
GRA    __
$a 1/0393/22 $p Ministry of Education, Slovakia.
LZP    __
$a Pubmed-20241015

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...